Neurostimulation for Treatment of Migraine and Cluster Headache
- PMID: 26177612
- PMCID: PMC4572909
- DOI: 10.1111/pme.12792
Neurostimulation for Treatment of Migraine and Cluster Headache
Abstract
Objective: The objective of this narrative review is to summarize the current state of neurostimulation therapies for the treatment of migraine and/or cluster.
Methods: For this narrative review, publications were identified by searching PubMed using the search terms "migraine" or "cluster" combined with "vagal nerve stimulation," "transcranial magnetic stimulation," "supraorbital nerve stimulation," "sphenopalatine ganglion stimulation," "occipital nerve stimulation," "deep brain stimulation," "neurostimulation," or "neuromodulation." Publications were chosen based on the quality of data that were provided and their relevance to the chosen topics of interest for this review. Reference lists of chosen articles and the authors' own files were used to identify additional publications. Current clinical trials were identified by searching clinicaltrials.org.
Results and conclusions: Neurostimulation of the vagal nerve, supraorbital nerve, occipital nerve and sphenopalatine ganglion, transcranial magnetic stimulation (TMS), and deep brain stimulation have been investigated for the treatment of migraine and/or cluster. Whereas invasive methods of neurostimulation would be reserved for patients with very severe and treatment refractory migraine or cluster, noninvasive methods of stimulation might serve as useful adjuncts to more conventional therapies. Currently, transcutaneous supraorbital nerve stimulation is FDA approved and commercially available for migraine prevention and TMS is FDA approved for the treatment of migraine with aura. The potential utility of each type of neurostimulation has yet to be completely defined.
Keywords: Cluster Headache; Deep Brain Stimulation; Migraine; Neurostimulation; Occipital Nerve Stimulation; Sphenopalatine Ganglion Stimulation; Transcranial Magnetic Stimulation; Transcutaneous Supraorbital Nerve Stimulation; Vagal Nerve Stimulation.
© 2015 Wiley Periodicals, Inc.
Figures
Similar articles
-
Neurostimulation for the treatment of chronic migraine and cluster headache.Acta Neurol Scand. 2019 Jan;139(1):4-17. doi: 10.1111/ane.13034. Epub 2018 Oct 29. Acta Neurol Scand. 2019. PMID: 30291633 Review.
-
Noninvasive neuromodulation in migraine and cluster headache.Curr Opin Neurol. 2018 Jun;31(3):268-273. doi: 10.1097/WCO.0000000000000557. Curr Opin Neurol. 2018. PMID: 29601305 Review.
-
Non-invasive Neuromodulation in Primary Headaches.Curr Pain Headache Rep. 2017 Mar;21(3):14. doi: 10.1007/s11916-017-0608-x. Curr Pain Headache Rep. 2017. PMID: 28271333 Review.
-
Neuromodulation for Chronic Daily Headache.Curr Pain Headache Rep. 2022 Mar;26(3):267-278. doi: 10.1007/s11916-022-01025-x. Epub 2022 Feb 7. Curr Pain Headache Rep. 2022. PMID: 35129825 Free PMC article. Review.
-
Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications.Curr Pain Headache Rep. 2025 Feb 15;29(1):47. doi: 10.1007/s11916-024-01314-7. Curr Pain Headache Rep. 2025. PMID: 39954214 Free PMC article. Review.
Cited by
-
From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.Cells. 2023 Nov 17;12(22):2649. doi: 10.3390/cells12222649. Cells. 2023. PMID: 37998384 Free PMC article. Review.
-
New Era of Electroceuticals: Clinically Driven Smart Implantable Electronic Devices Moving towards Precision Therapy.Micromachines (Basel). 2022 Jan 22;13(2):161. doi: 10.3390/mi13020161. Micromachines (Basel). 2022. PMID: 35208286 Free PMC article. Review.
-
Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials.Neurol Sci. 2022 Jan;43(1):153-165. doi: 10.1007/s10072-021-05664-7. Epub 2021 Oct 26. Neurol Sci. 2022. PMID: 34698941 Review.
-
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials.J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):796-804. doi: 10.1136/jnnp-2018-320113. Epub 2019 Mar 1. J Neurol Neurosurg Psychiatry. 2019. PMID: 30824632 Free PMC article.
-
Visualizing the trigeminovagal complex in the human medulla by combining ex-vivo ultra-high resolution structural MRI and polarized light imaging microscopy.Sci Rep. 2019 Aug 5;9(1):11305. doi: 10.1038/s41598-019-47855-5. Sci Rep. 2019. PMID: 31383932 Free PMC article.
References
-
- Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–36. - PubMed
-
- Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002;22:633–58. - PubMed
-
- Shamliyan TA, Kane RL, Taylor FR. Migraine in Adults: Preventive Pharmacologic Treatments. Rockville (MD): 2013. - PubMed
-
- Ashkenazi A, Schwedt T. Cluster headache--acute and prophylactic therapy. Headache. 2011;51:272–86. - PubMed
-
- Lenaerts ME, Oommen KJ, Couch JR, Skaggs V. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous